Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries
- PMID: 2469247
- DOI: 10.1007/BF00734084
Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries
Abstract
The localization of S-protein/Vitronectin as deposits in arterial lesions and as a component of extracellular matrices was investigated by indirect immunofluorescence in ten atherosclerotic samples of carotid endarterectomy compared with ten arteriosclerotic temporal biopsies. Anti-C5b-9 neoantigens, anti-C3, anti-C3d, anti-H, anti-IgG and anti-IgM antibodies were applied on serial sections. In the atherosclerotic plaque, S-protein deposits were observed as irregular granules and spots in the fibrous cap and the internal part of the media at the vicinity of the plaque; they inconstantly colocalized with C5b-9 neoantigens. When present the SC5b-9 complexes were generally associated with cell remnants in the sclerotic matrix. In the temporal artery biopsies, S-protein was bound exclusively to the internal elastic lamina in association with C3d, but was absent from the intimal fibrous thickening. S-protein was not detected as a diffuse component of the extra-cellular matrix of either musculo-elastic or muscular medias, but was clearly demonstrated in smaller arteries; this result suggests a differential distribution of S-protein along the arterial tree.
Similar articles
-
Immunoelectron-microscopic localization of S-protein/vitronectin in human atherosclerotic wall.Atherosclerosis. 1989 Aug;78(2-3):197-203. doi: 10.1016/0021-9150(89)90223-2. Atherosclerosis. 1989. PMID: 2476993
-
Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis.Atherosclerosis. 1987 May;65(1-2):1-11. doi: 10.1016/0021-9150(87)90002-5. Atherosclerosis. 1987. PMID: 2955791
-
Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.Arterioscler Thromb. 1993 Jul;13(7):1090-100. doi: 10.1161/01.atv.13.7.1090. Arterioscler Thromb. 1993. PMID: 7686395
-
Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture.Cardiovasc Res. 1999 Feb;41(2):361-8. doi: 10.1016/s0008-6363(98)00212-0. Cardiovasc Res. 1999. PMID: 10341835 Review.
-
[Arterial wall texture after uncomplicated endarterectomy].Pathologe. 1995 Sep;16(5):336-41. doi: 10.1007/s002920050111. Pathologe. 1995. PMID: 7479606 Review. German.
Cited by
-
Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.J Cell Biol. 1990 Sep;111(3):1283-91. doi: 10.1083/jcb.111.3.1283. J Cell Biol. 1990. PMID: 1697297 Free PMC article.
-
Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.Clin Exp Immunol. 1993 Aug;93(2):242-7. doi: 10.1111/j.1365-2249.1993.tb07973.x. Clin Exp Immunol. 1993. PMID: 8348751 Free PMC article.
-
Matricellular proteins in atherosclerosis development.Matrix Biol. 2023 Jun;120:1-23. doi: 10.1016/j.matbio.2023.04.003. Epub 2023 Apr 20. Matrix Biol. 2023. PMID: 37086928 Free PMC article. Review.
-
Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes.Histochem Cell Biol. 1996 Mar;105(3):195-201. doi: 10.1007/BF01462292. Histochem Cell Biol. 1996. PMID: 8681037
-
Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin.Mol Neurodegener. 2008 Oct 21;3:16. doi: 10.1186/1750-1326-3-16. Mol Neurodegener. 2008. PMID: 18939994 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous